NCT00652912View on ClinicalTrials.gov

Bioavailability Study of Clonazepam ODT Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

April 30, 2004

Study Completion Date

May 31, 2004

Conditions
To Determine Bioequivalence Under Fasting Conditions
Interventions
DRUG

Clonazepam

ODT, 1 mg

DRUG

Klonopin Wafers

ODT, 1 mg

Sponsors
All Listed Sponsors
collaborator

Cetero Research, San Antonio

NETWORK

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT00652912 - Bioavailability Study of Clonazepam ODT Under Fasting Conditions | Biotech Hunter | Biotech Hunter